Acurx Announces Scientific Oral and Poster Presentations at IDWeek

Oct 17, 2022

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides Business Update

Aug 15, 2022

Acurx Pharmaceuticals, Inc. to Discuss 2022 Second Quarter Financial Results on August 16, 2022 Conference Call and Provide Business Update

Aug 4, 2022

Acurx Announces New Data Presentations from Ongoing Ph2 Clinical Trial Program of Ibezapolstat for CDI at the 16th Biennial Congress of the Anaerobe Society of America

Aug 2, 2022

Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering

Jul 25, 2022

Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update

May 11, 2022

Acurx Pharmaceuticals, Inc. to Discuss 2022 First Quarter Financial Results on May 11, 2022 Conference Call and Provide Business Update

Apr 29, 2022

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update

Mar 17, 2022

Acurx Pharmaceuticals to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28-30, 2022 from 9:00 a.m. - 5:00 p.m. EDT

Mar 16, 2022

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update

Mar 7, 2022